The observed and relative survival of prostate cancer patients
Merabishvili, V.M.; Atroshchenko, A.V.; Kharitonov, M.V.
Voprosy Onkologii 60(5): 563-570
2014
ISSN/ISBN: 0507-3758 PMID: 25816659 Document Number: 674602
Prostate cancer refers to tumor sites with the most favorable prognosis. Prostate cancer is a tumor that affects mainly elderly and senile age groups. For the first time in Russia there were performed estimations of the observed and relative survival of patients with prostate cancer according to the age and stage of disease. Presented calculations could be used as reference material on survival of prostate cancer patients.
Document emailed within 1 workday
Related Documents
Ragde, H.; Grado, G.L.; Nadir, B.S. 2001: Brachytherapy for clinically localized prostate cancer: thirteen-year disease-free survival of 769 consecutive prostate cancer patients treated with permanent implants alone Archivos Espanoles de Urologia 54(7): 739-747Cresswell, J. 1997: New method for expressing survival in cancer. use of age specific relative survival is sufficient Bmj 315(7119): 1376
Asselain, B. 1997: Long-term survival in patients with localized prostate cancer Revue d'Epidemiologie et de Sante Publique 45(4): 347-348
Zharinov, G.M.; Zimin, A.A.; Samoĭlova, K.A.; Neklasova, N.I. 2011: Survival among patients with prostate cancer after distant radiotherapy and low-intensity near-infrared phototherapy Voprosy Onkologii 57(4): 457-461
Aaltomaa, S.; Kärjä, V.; Lipponen, P.; Isotalo, T.; Kankkunen, J.P.; Talja, M.; Mokka, R. 2006: Expression of Ki-67, cyclin D1 and apoptosis markers correlated with survival in prostate cancer patients treated by radical prostatectomy Anticancer Research 26(6c): 4873-4878
Arisue, T.; Tamura, K.; Tebayashi, A. 1988: End results of gastric cancer detected by mass survey: analysis using the relative survival rate curve Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(4 Pt: 2-1): 929-936
Roach, M. 1998: Is race an independent prognostic factor for survival from prostate cancer? Journal of the National Medical Association 90(11 Suppl): S713-S719
Stephenson, R.A.; James, B.C.; Gay, H.; Fair, W.R.; Whitmore, W.F.; Melamed, M.R. 1987: Flow cytometry of prostate cancer: relationship of DNA content to survival Cancer Research 47(9): 2504-2507
De la Taille, A.; Houlgatte, A.; Houdelette, P.; Berlizot, P.; Ramirez, J.; Ricordel, I. 1997: Value of free/total prostate specific antigen in the early diagnosis of prostate cancer (study of 105 patients) Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 7(2): 240-245
O'Dell, K.J.; Volk, R.J.; Cass, A.R.; Spann, S.J. 1999: Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions? Journal of Family Practice 48(9): 682-688
Briglia, R.; Calcina, G.G.; Pera, M.; Zambarda, E. 1983: Cancer of the stomach operated on for peptic ulcer. 10 cases observed in 185 gastric cancer patients Minerva Chirurgica 38(13-14): 1131-1134
Zhang, S.-g.; Wang, Y.-h.; Ding, Y.; Wu, Y. 2005: Long term survival results in advanced prostate cancer treated with combined androgen blockade Zhonghua Nan Ke Xue 11(10): 770
Aaltomaa, S.; Kärjä, V.; Lipponen, P.; Isotalo, T.; Kankkunen, J.P.; Talja, M.; Mokka, R. 2005: Reduced alpha- and beta-catenin expression predicts shortened survival in local prostate cancer Anticancer Research 25(6c): 4707-4712
Breeuwsma, A.J.; Rybalov, M.; Leliveld, A.M.; Pruim, J.; de Jong, I.J. 2012: Correlation of [11C]choline PET-CT with time to treatment and disease-specific survival in men with recurrent prostate cancer after radical prostatectomy Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 56(5): 440-446
Utomo, N.B.; Mochtar, C.A.; Umbas, R. 2012: Primary hormonal treatment in localized and locally advanced prostate cancer: effectiveness and survival predictive factors Acta Medica Indonesiana 44(1): 10-15
Rosser, C.J.; Kuban, D.A.; Lee, S-Joon.; Levy, L.B.; Pettaway, C.; Kamat, A.M.; Chichakli, R.; Lee, A.; Cheung, R.M.; Sanchez-Ortiz, R.; Pisters, L.L. 2004: Racial influence on biochemical disease-free survival in men treated with external-beam radiotherapy for localized prostate cancer Journal of the National Medical Association 96(7): 939-944
Stenman, U.H.; Leinonen, J.; Alfthan, H.; Rannikko, S.; Tuhkanen, K.; Alfthan, O. 1991: A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer Cancer Research 51(1): 222-226
Ngo, L.S.M.; Yeo, A.; Wong, A.S.C.; Tay, M.Hiang. 2007: Efficacy of low-dose ketoconazole in hormone refractory prostate cancer patients at the National Cancer Centre and The Cancer Institute, Singapore Annals of the Academy of Medicine Singapore 36(10): 811-814
Murray, N.P.; Aedo, S.óc.; Reyes, E.; Fuentealba, C.; Jacob, O. 2019: Primary circulating prostate cells, age and prostatic volumen predict the presence of prostate cancer in men with indication of a second prostate biopsy Archivos Espanoles de Urologia 72(1): 16-24
Romppanen, J.; Haapalainen, T.; Punnonen, K.; Penttilä, I. 2002: Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer Anticancer Research 22(1a): 415-420